Affiliation:
1. Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal
2. Coimbra Chemistry Centre, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal
3. Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, The Netherlands
Abstract
This review outlines the evolutionary journey from traditional two-dimensional (2D) cell culture to the revolutionary field of organ-on-a-chip technology. Organ-on-a-chip technology integrates microfluidic systems to mimic the complex physiological environments of human organs, surpassing the limitations of conventional 2D cultures. This evolution has opened new possibilities for understanding cell–cell interactions, cellular responses, drug screening, and disease modeling. However, the design and manufacture of microchips significantly influence their functionality, reliability, and applicability to different biomedical applications. Therefore, it is important to carefully consider design parameters, including the number of channels (single, double, or multi-channels), the channel shape, and the biological context. Simultaneously, the selection of appropriate materials compatible with the cells and fabrication methods optimize the chips’ capabilities for specific applications, mitigating some disadvantages associated with these systems. Furthermore, the success of organ-on-a-chip platforms greatly depends on the careful selection and utilization of cell resources. Advances in stem cell technology and tissue engineering have contributed to the availability of diverse cell sources, facilitating the development of more accurate and reliable organ-on-a-chip models. In conclusion, a holistic perspective of in vitro cellular modeling is provided, highlighting the integration of microfluidic technology and meticulous chip design, which play a pivotal role in replicating organ-specific microenvironments. At the same time, the sensible use of cell resources ensures the fidelity and applicability of these innovative platforms in several biomedical applications.
Funder
Fundação para a Ciência e a Tecnologia
Coimbra Chemistry Centre
Santander Universidades
Reference113 articles.
1. Jensen, C., and Teng, Y. (2020). Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front. Mol. Biosci., 7.
2. Two-Dimensional (2D) and Three-Dimensional (3D) Cell Culturing in Drug Discovery;Ntwasa;Cell Cult.,2019
3. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer;Imamura;Oncol. Rep.,2015
4. In vitro 2D and 3D cancer models to evaluate compounds that modulate macrophage polarization;Larsen;Cell. Immunol.,2022
5. Park, Y., Huh, K.M., and Kang, S.W. (2021). Applications of biomaterials in 3d cell culture and contributions of 3d cell culture to drug development and basic biomedical research. Int. J. Mol. Sci., 22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献